Braveheart Bio
United States · $185.0M raised
- Total Funding
- $185.0M
- Last Round
- $185.0M Series ANov 2025
- Rounds
- 1
About
Biotech company focused on cellular therapeutics.
Summary
Braveheart Bio is a Biotech company based in United States. It has raised $185.0M in total across 1 round, most recently a $185.0M Series A round in Nov 2025. Investors include Andreessen Horowitz, Forbion Capital Partners and OrbiMed.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Nov 2025
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company